Understanding how Kindlin-2 interacts with cell membranes
Atomic Resolution Characterization of Kindlin-2 Binding to Phosphatidylinositol Phosphatases in Lipid Bilayers by Solid-State NMR
This study is looking at how a protein called Kindlin-2 interacts with certain fats in our cells, which could help us understand more about diseases like cancer and diabetes, and possibly lead to new treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-10888422 on NIH RePORTER |
What this research studies
This research investigates the interactions between Kindlin-2, a protein that plays a crucial role in cell adhesion, and lipid membranes. By using solid-state NMR, the study aims to gain detailed insights into how Kindlin-2 binds to specific lipids, particularly phosphatidylinositol phosphates, which are vital for various cellular processes. The research seeks to uncover the mechanisms behind these interactions, which could have implications for diseases like cancer and diabetes. Patients may benefit from a better understanding of these processes, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by conditions related to cell adhesion and signaling, including certain cancers and diabetes.
Not a fit: Patients with conditions unrelated to cell adhesion or lipid signaling may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and treatments for diseases related to cell adhesion and signaling, such as cancer and diabetes.
How similar studies have performed: While the specific approach of using solid-state NMR for this type of investigation is relatively novel, similar studies have shown promise in understanding protein-lipid interactions.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Nieuwkoop, Andrew — Rutgers, the State Univ of N.j.
- Study coordinator: Nieuwkoop, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.